The development of hepatocellular carcinoma (HCC) is generally preceded by cirrhosis, which occurs at the end stage of fibrosis. This is a common and potentially lethal problem of chronic liver disease in Asia. The development of microarrays permits us to monitor transcriptomes on a genome-wide scale; this has dramatically speeded up a comprehensive understanding of the disease process. Here we used dimethylnitrosamine (DMN), a nongenotoxic hepatotoxin, to induce rat necroinflammatory and hepatic fibrosis. During the 6-week time course, histopathological, biochemical, and quantitative RT-PCR analyses confirmed the incidence of necroinflammatory and hepatic fibrosis in this established rat model system. Using the Affymetrix microarray chip, 256 differentially expressed genes were identified from the liver injury samples. Hierarchical clustering of gene expression using a gene ontology database allowed the identification of several stage-specific characters and functionally related clusters that encode proteins related to metabolism, cell growth/maintenance, and response to external challenge. Among these genes, we classified 44 potential necroinflammatory-related genes and 62 potential fibrosis-related markers or drug targets based on histopathological scores. We also compared the results with other data on wellknown markers and various other microarray datasets that are available. In conclusion, we believe that the molecular picture of necroinflammatory and hepatic fibrosis from this study may provide novel biological insights into the development of early liver damage molecular classifiers than can be used for basic research and in clinical applications. A public accessible website is available at http://LiverFibrosis.nchc.org.tw:8080/LF.
INTRODUCTION
of factors, such as hepatitis B virus (HBV), hepatitis C virus (HCV), hepatotoxins, metabolic disorders, and alcoholism, can induce liver cirrhosis, hepatic fiLiver fibrosis and cirrhosis, which appear during the end stage of fibrosis, are the major risk factors of brogenesis is also induced by these risk factors and shares a similar phenotype (4, 8, 20, 23, 39) . However, hepatocellular carcinoma (HCC). Although a range 108 SU ET AL.
it is not clear what types of genes are involved or enabled us to identify 256 differentially expressed genes, including 44 necroinflammatory-related and how they act when liver injury takes place and is repaired. Moreover, the cirrhosis caused by these risk 62 fibrosis-related genes. Comparison of our dataset with earlier related studies reveals multiple overlapfactors often progresses insidiously. Patients with endstage liver cirrhosis usually die unless they accept ping gene identities and these may potentially serve as markers for fibrosis, cirrhosis, and/or HCC diagnoliver transplantation, which has a 5-year survival rate of 75% (23) .
sis. Finally, the histopathological, clinical biochemical, and microarray data are stored at http://Liver Previous biochemical studies have reported that there are 39 well-known fibrosis or cirrhosis markers Fibrosis.nchc.org.tw:8080/LF to allow the scientific community to freely access this invaluable informa- (13, 19, 23) and these include invasive and noninvasive markers. Recently, the development of microtion and knowledge. arrays, which permit us to monitor transcriptomes on a genome-wide scale, has dramatically expedited a comprehensive understanding of gene expression MATERIALS AND METHODS profiles and this includes how the transcription profiles for genes vary across the progressive of a disAnimal Treatments ease's development. Moreover, the application of mi-DMN-induced liver fibrosis model was performed croarray may ultimately reveal unique and identifiable as previously described (25). Male Sprague-Dawley signatures, which are essential to the discovery of rats (Slc:SD; Japan SLC, Shizuoka, Japan), weighing new insights into the mechanisms common to, for ex-300-350 g, were used in all experiments. To induce ample, liver fibrosis. Recently, two microarray studhepatic fibrosis over a 6-week time course experiies have been carried out that relate to liver fibrosis ment, the rats were given DMN (Sigma, St. Louis, and cirrhosis. Firstly, liver fibrosis was induced in MO) by IP injection. The chemical was dissolved in rats by continuous administration of thioacetamide normal saline and injected three consecutive days a (TAA) in the drinking water for 12 weeks. The liver week at a dose of 6.7 mg/kg per body weight. This samples at a single time point (14th week) were is a much lower dosage than the one used in other subjected to the Agilent Rat cDNA microarray analexperiments where the level was 100 mg/kg/day ysis (45). Secondly, Kim and his colleagues identi-DMN. This higher level is able to cause toxicity in fied 556 chronic liver disease (CLD)-related genes, rat liver (47, 48) . The treatment with DMN lasted for which included 273 HCC-associated gene signaonly the first 3 weeks (Fig. 1A ). Four to seven rats tures and 283 etiology-associated signatures; this at each time point for each group were treated with involved a comparison of low-risk and high-risk either DMN or with an equal volume of normal saline CLD groups using an Incyte human cDNA microwithout DMN as the control. All of these rats (26 array (26) . Thirdly, it is well known that the liver DMN-treated rats and 24 control rats) were subjected regenerates in response to a variety of injuries to biochemical and histopathological analysis. How- (10, 34) . Rodent partial hepatectomy has been a useever, only two rats for each group at each time point ful tool and model with which to investigate the sigwere subjected to microarray analysis. Rats were nals that regulate the regenerative response. White weighed and sacrificed on days 11, 18, 25, 32, 39, and his colleagues used a microarray strategy to and 46 and these were designated as weeks 1 through identify a total of 640 different expression pattern 6 (Fig. 1A) . genes that are involved in the hepatic regenerative response (50) .
Several animal models have been established to Serum Biochemical Data study liver fibrosis (7, 17, 40, 45) . In this study, we employed dimethylnitrosamine (DMN), which is a poBlood samples, collected from the animals at necropsy, were used to measure serum concentrations or tent nongenotoxic hepatotoxin, to simulate liver fibrosis (16, 37) and to perform a 6-week time course activity of albumin, glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), Affymetrix microarray study. DMN has been demonstrated to induce liver damage rapidly and also has total bilirubin, acid phosphatase (ACP), α-fetoprotein (AFP), blood urea nitrogen (BUN), lactate dehydrobeen empirically proven to be useful for the study of early human fibrosis formation (1, 14, 25) . Moreover, genase (LDH), globulin, prothrombin time (PT), and blood platelets (PLT) using an Hitachi 747 and ACL the implementation of histopathological grading of each rat and a statistical approach allows quantitative 3000 clinical chemistry analyzer system (MYCO, Renton, WA) at Taichung Veterans General Hospital, depiction of the transcriptional regulation during liver fibrosis over a time course. The expression patterns
Taiwan.
the measurements. The relationship between the exand fifth to sixth week) for statistical analysis. The biochemical data of all DMN-treated subgroups perimental chips was analyzed by linear regression. The similarity between Q-RT-PCR and microarray
showed abnormal values when compared with controls, as illustrated in Table 1 . Two-way ANOVA at data of Timp1 was analyzed by Pearson's correlation coefficients. The differentially regulated genes from a 5% significance level was performed to distinguish the various variations (e.g., treatment vs. controls and microarray data were identified based on the Student's t-test at the 1% significance level. Furtherdifferences due to the time course) and to estimate the variance of each individual variable in the more, the necroinflammatory and fibrosis associated genes were calculated by statistic analysis. Least ANOVA model. The results are shown in Table 2 . No significant differences (p < 0.05) were present in squares means (LSM), separately estimated for each three-subgroup variation according to necroinflam- the baseline values of all parameters evaluated in the control groups (data not shown). When the DMNmatory score, were used for the necroinflammatoryrelated analysis. The Student's t-test was used for the treated and controls were compared, there were 10 serum markers that showed significant differences, fibrosis-related analysis as it was based on a twosubgroup variation in fibrosis score. A p value of less including albumin, glutamic pyruvic transferase (GPT), glutamic oxaloacetic transferase (GOT), bilithan 0.05 was considered to be statistically significant.
rubin, alkaline phosphatase (AKP), α-fetoprotein (AFP), cholesterol (CHOL), blood urea nitrogen (BUN), prothrombin time (PT), and platelet count (PLT). These differences were not due to changes RESULTS over the time course (1-6 weeks). In contrast, two-
Establishment of the DMN-Induced Rat Hepatic
way ANOVA analysis indicated that the time course
Fibrosis Model
showed an effect on lactate dehydrogenase (LDH), globulin, and acid phosphatase (ACP). Taken toTo monitor the process of liver fibrosis, we set up gether, the biochemical data for the DMN-treated the DMN-induced rat hepatic fibrosis animal model group suggest that there were changes in many serum as described in Materials and Methods. Schematimarkers and that the protein expression levels or cally, this model is shown in Figure 1 . Over the timephysical responses are similar to liver damage phenoline of 6 weeks, 26 rats were treated with DMN and types in human (21, 28 ). 24 rats were treated with saline (4-7 rats for each group at each time point). In agreement with previous observations (14) , after 3 weeks of DMN treatment, Gene Expression Profiling During DMN-Induced collagen fiber deposition in rat liver could be obLiver Damage served, along with bile duct proliferation, centrilobuOver the 6-week time course experiment, the liver lar necrosis, bridging fibrosis, and fibrosis surroundsamples of 12 controls and 12 DMN-treated rats (2 ing the central veins (see below for a detailed rats for each time point) were selected and microarray description). To gain additional information about the experiments performed on them. Before any statistiestablished animal model, the gene expression profile cal analyses were applied to the microarray data, reof tumor growth factor-beta 1 (Tgfb1), which is the producibility was assessed. Genes were selected as strongest known inducer of fibrogenesis in the efpresent when they were assigned a present call acfecter cells of hepatic fibrosis and can stimulate the cording to the perfect match (PM)/mismatch (MM) adipocyte transformation (5, 9, 15, 41) , was evaluated.
algorithm of Affymetrix in all gene chips (31). Of the The Q-RT-PCR result showed that a higher level of 8799 probe sets analyzed, overall expression patterns Tgfb1 mRNA expression was observed in DMNfor 2385 transcripts on the chips were reported to be treated rat livers than in the controls (Fig. 1B) . These present (p < 0.04). To verify that intrasample variinitial examinations warrant further characterization ability did not obscure differences between the conof the DMN-induced rat hepatic fibrosis model. trols and DMN-treated groups, as well as to determine the fold change that we should consider to be Clinical Biochemistry Results significant, we compared the expression profiles among the 24 control datasets. Scatter graphs of exThe serum of each rat, 50 rats in total, was subjected to various biochemical examinations related to pression levels of the 2385 transcripts represented on the microarray were compared with each other. Figliver damages. These examinations are shown in Table 1. The variable marker values of the control and ure 2A shows the duplicate samples at week 4. Overall, there was no statistical difference at all, with DMN-treated rats were further divided into three subgroups (first to second week, third to fourth week, 3.2% of the transcripts deviated more than twofold. Each rat was either injected with DMN three times per week for 3 consecutive weeks (triangle) or injected with normal saline as a control under the same regime. Rats were weighed and sacrificed each week (starting on day 11, which are referred to as first week to sixth week). Blood samples were collected for biochemical assay (summary in Table 1 ) and livers were excised and weighed, followed by either fixing in formaldehyde for histopathology or isolation of RNA for microarray analysis. (B) The quantitative real-time PCR result for Tgfb1. The TaqMan assays were conducted in triplicate for each sample, and a mean value was used for calculation of expression levels. To standardize the quantification of the target genes, 18S rRNA from each sample was quantified at the same time as the target genes.
To investigate the time course variability, the reliable transcripts as previous described. Of these, 268 were differentially expressed transcripts either higher or signals of these 2385 probe sets between the first and sixth week of controls were calculated. Again, they lower by 1.5-fold or more when compared with the controls and DMN-treated groups. The second method, were no statistically difference, with 4.6% of the transcripts deviated more than twofold (Fig. 2B) . In conwhich used the "detection flag" selection (31), reported 23 transcripts to be "present" in the DMNtrast, a significant scatter was found between controls and DMN-treated groups, with 28.7% of the trantreated groups but not in the controls. In contrast, there was only one transcript reported to be "absent" scripts deviated more than twofold (Fig. 2C) .
We further investigated whether the controls and in all DMN-treated groups but not in the controls. Altogether, 256 genes (or 292 transcripts), including DMN-treated groups could be classified into groups on the basis of their gene expression profiles. As the 137 upregulated and 119 downregulated genes, exhibited a differentially expressed gene expression patfirst step to minimize the likelihood of false positives, we filtered all transcripts by forming two independent tern when the DMN-treated groups and controls were compared. Detailed descriptions of all 256 genes inclusters from the microarray data and identified those that were potentially differentially expressed (Fig. 3) .
cluding GeneBank ID, name, and fold change are shown in Table 3 and on our liver fibrosis website For detailed analysis, the first cluster generated 2385 Values are mean ± SD from 1-2-, 3-4-, or 5-6-week treated and untreated groups. n: number of rats. GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase; bilirubin, total bilirubin; AKP, alkaline phosphatase; LDH, lactate dehydrogenase; AFP, α-fetoprotein; CHOL, cholesterol; BUN, blood urea nitrogen; ACP, acid phosphatase; PT, prothrombin time; PLT, blood platelet.
(see below). Hierarchical clustering generated a denshown in Figure 4B . A hierarchical clustering was further employed to organize each of these top three drogram for the gene expression patterns of these 292 transcripts across the 24 samples as shown in Figure  categories of biological process into a dendrogram (Fig. 4C ). 4A.
These 256 genes were further classified on biologiTo validate our microarray data, Q-RT-PCR analysis was performed for tissue inhibitor of metalloprocal process, molecular function, and cellular component involved based on gene ontology analysis (http: teinase 1 (Timp1), tissue inhibitor of metalloproteinase 2 (Timp2), matrix metalloproteinase 3 (Mmp3), //fatigo.bioinfo.cipf.es/) (2). In either category, the largest proportion (approximately 50%) was found to and gamma-glutamyl transpeptidase (Ggtp). These genes were chosen for validation because these genes be uncharacterized genes and the summary results are were identified both in this GeneChip study and in previous studies. As determined by Q-RT-PCR, TABLE 2 Timp1 (Fig. 4D) (Fig. 4E) , suggesting that Spp1 may be a potential early diagnostic marker for patients with inflammation and fibrosis.
Histopathology Results
To capture the progression of liver damage, a scoring system, as described in detail in Materials and Methods was used to characterize the phenotypic changes as the result of DMN-induced liver damages (Fig. 5A ). There are three histopathological gradings in this study, including necroinflammatory (A0-A6), which is the sum of necrosis (N0-N3) and inflamma- Figure 3 . Flowchart of steps for implementation of statistical protocols and our comprehensive cutoff points for data mining. Transcripts (2409) were filtered in control group and DMN-treated group. One and 24 transcripts were clustered as all present in the control but all absent in the DMN-treated group and all present in the DMN-treated but all absent in control group, respectively. In Figure 2 . Interactive scatter plot display of the absolute intensity total, 2385 present transcripts were clustered from all 24 chips. All values for the 2385 unique transcripts represented on the Gene reliable transcripts were found to have similar expression pattern Chip. (A) Biological variability of s in the duplicate experiments as genes that are well known as fibrosis markers by Pearson corre-(C41 and C42); 3.2% of transcripts deviated more than twofold. lation (r > 0.8). A further 268 transcripts were further filtered as (B) Biological variability of s from the first versus sixth week (C12 showing a 1.5-fold change from the initial 2385 genes. Two hunand C62); 4.6% of transcripts deviated more than twofold. (C) Biodred and ninety-two transcripts (256 genes) were identified and logical variability between the control and DMN-treated rats at the subjected to more detailed analysis including gene ontology detecfourth week (C41 and D42); 28.7% of transcripts deviated more tion and histopathology (necroinflammatory and fibrosis)-related than twofold.
genes analysis. Genes are ranked by fold change. Significance was calculated using the t-test.
tion (I0-I3) scores, fibrosis (F0-F3), and fatty orrhagic confluent necrosis, combined with portal inflammation, was found in most DMN-treated rats change (classified as presence or absence; +/−). In the first 2 weeks, bridging (N2, 50%) and hemorrhagic (A4-6, 64%). However, in the fifth to sixth week, both necrosis and inflammation had disappeared (A0, confluent necrosis (N3, 50%) were found in all rats treated with DMN. By the third to fourth week, hem-44%) or had regressed to a low level (A1-3, 44%) in small regions. orrhagic confluent necrosis (N3) was found in most DMN-treated rats (91%). In the last 2 weeks, necrosis Seventy-five percent of the DMN-treated rats had none (F0) or low levels of fibrosis (F1) in the first 2 disappeared or regressed to a low level in small regions (N1, 12.5%). In addition, our data also suggest weeks. By the third to fourth week, nearly 90% of the DMN-treated rats had high levels of fibrosis, from that the 3-week treatment with a low dose of DMN induced diffuse bridging necrosis without steatosis in bridging fibrosis (F2) to frequent bridging fibrosis with focal nodule formation (F3). In the last 2 weeks, this rat model system. Similarly, the majority of the DMN-treated rats displayed high inflammatory infil-F2 and F3 were still present in 78% of DMN-treated rats. The fatty changes were only present in a few tration, ranging from moderate (I2, 50%) to marked (I3, 50%), during the first 2 weeks. By the third to treated rats (3.7%). In contrast, there were no abnormal pathological patterns present in the control group fourth week, the intensity of inflammatory cell infiltration at portal areas was still high in most DMNat all (Fig. 5B ). In addition, no clear abnormality was found in the kidney or spleen of the DMN-treated treated rats (I2, 54.5% and I3, 27.2%). In the last 2 weeks, a significant regression of liver damage to a and normal rats (data not shown). All of the histopathological datasets have been deposited on our low level in small regions (I0, 75% and I1, 12.5%) was observed. Together, for the combined necrosis liver fibrosis website (see below). Together, the detailed necroinflammatory and fibrosis scoring sysand inflammation scores, mild (A1-3, 62.5%) and moderate necroinflammatory (A4-6, 36.5%) patterns tems of the process of the DMN-induced liver damage suggest that dramatic necrosis and inflammation were found in all rats treated with DMN in the first 2 weeks (Fig. 5B) . By the third to fourth week, hemtook place during early liver damage progression Necroinflammatory change was divided into three grades: A0 = "no," A(1-3) = "mild," and A(4-6) = "moderate" necroinflammation. Fibrosis is divided into two grades: F(0-1) = "normal to fibrous expansion of portal tracts" and F(2-3) = "bridge fibrosis to frequent bridging fibrosis with nodule formation." The fatty change is shown as presence or absence (+/−). The number of rats was counted and used to calculate the percentage of each histopathological level at each time point.
(weeks 1-4) and this was followed by hepatic bridgData Comparison ing fibrosis at 3-6 weeks.
To assess the validity of our expression cassette of genes for distinguishing liver damage from rat liver Necroinflammatory and Fibrosis Candidate Genes sample specimens, we explored the overlap between our data and other published studies. We compared Necroinflammatory and fibrosis have been suggested to play important roles in liver cirrhosis prowith four datasets. First was the intersection between our 256 significant genes and the Utsunomiya et al. gression in the rat model (1, 13, 24, 25, 27) . To clarify the factors responsible for this histopathological phegene lists, which identified 100 differentially expressed genes in TAA-induced liver fibrosis using rat notype, all rat samples were classified by histopathological evaluation with histopathological scores for cDNA microarray (45). Of these 100 genes, 14 genes, including 7 genes upregulated and 7 genes downregunecroinflammatory (A0-A6) and fibrosis (F0-F3) as describe in Figure 5B . Comparing mRNA expression lated, overlapped with th our most significant 256 gene list as shown in Table 6 . Failure to detect the levels from microarray data, 44 genes were identified by expression level to be significantly correlated with remaining genes is probably due to most of them having "absent" calls in Affymetrix chips. Therefore, none to higher scores by the LSM method at the 5% significance level, which was separately estimated for these genes did not qualify under the conditions of our analysis. Alternatively, TAA and DMN might ineach three-subgroup variation in necroinflammatory score ( Fig. 6A and Table 4 ). Of these 44 genes, 33 duce different responses during liver fibrosis. In addition, there can be substantial variation in the data, of them were expressed at higher levels in liver with necroinflammation compared to the normal liver and which can be generated across multiple microarray platforms during the course of data analysis. Thereof these nine were membrane or extracellular proteins as annotated by gene ontology (Fig. 6A) . These nine fore, it is not surprising that only a few genes overlapped in this data comparison (44) . Secondly, to genes might have potential to serve as marker signatures for necroinflammation. Among these 44 genes, allow a comparison against microarray data from patients with cirrhosis (26), we converted the most sigthe results for two of them [endothelial cell-specific molecule 1 (Esm1) and vimentin (Vim)] are consisnificant 256 rat genes by the GeneSpring software homology table and the HomoloGene NCBI database tent with previous studies that examined individual markers (see the Discussion) (6, 38) .
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db= homologene) into their human ortholog genes, and Using the Student's t-test, 62 differentially expressed genes (32 upregulated and 30 downregulated) 213 genes were listed. From studies by Kim and his colleagues, the results showed that 8 genes, including between the F0-1 and F2-3 level of fibrosis were identified at the 5% significance level, estimated us-6 genes in the hepatocellular carcinoma-associated signature table and 2 genes in etiology-associated siging only two subgroup variations for the fibrosis score (Fig. 6C, and Table 5 ). Similarly, annotation nature table overlapped with our most significant human homolog gene list (26) ( Table 6 ). Even though based on the gene ontology database revealed that there were 15 membrane and extracellular proteins only a few genes overlapped in this data comparison, these 213 gene expression pattern changes might aid that showed a fibrosis signature. In agreement with previous studies, three genes, including Timp1, for the detection of human early liver injury. Thirdly, the liver sample response to injury includes both he-CD63, antigen (Cd63), and annexin A1 (Anxa1), exhibited similar gene expression patterns during liver patic bridging fibrosis and regeneration with the outcome determined by the injury (46) . On comparing fibrosis (3, 22, 32, 43) . These necroinflammatory and fibrosis-associated gene expression patterns were White's study (50) with our 256 genes, there were 21 upregulated and 13 downregulated genes that ocplotted over the time course (Fig. 6B, 6D) . The color corresponds to relative gene expression using the first curred in both datasets. These overlapping genes might be referred to as liver regeneration signatures. week as the control. These observations indicated that oligo-microarray analysis is a powerful approach for Finally, 14 out of 39 well-known fibrosis markers (13, 19, 23) could be found in our results (Supplemenmonitoring molecular events during liver injury and repair where the pathogenesis is unknown, and these tal Table 1 ). Two, including Timp1 and Timp2, out of 14 genes share similar gene expression patterns to signature genes could discriminate successfully between the low-score and the high-score histopatholthe human liver damage phenotype against our microarray dataset, as shown in Supplemental Table 2 . ogy groups. Together, the genes would seem to be responsible for the early stage formation of necroin-
The results suggest that these findings from a study generated using an animal model system should be flammation and fibrosis; thus, we believe they are possible early markers for the detection of fibrosis.
extendable to clinical studies. When the liver is sub- Figure 6 . The associated genes related to necroinflammatory and fibrosis progression. The genes related to the necroinflammatory (A) and fibrosis scores (C) were filtered from the 256 genes by their different fibrosis levels. Both upregulated and downregulated expression patterns of the necroinflammatory or fibrosis-related genes were compared against the patterns at score A0 or F0. Altogether 44 genes (35 genes and 9 ESTs) were found to be related to necroinflammatory and 62 genes (48 genes and 14 ESTs) were found to be related to the fibrosis process. Both the necroinflammatory and fibrosis-associated gene expression patterns were plotted against a time course (B and D). The color corresponds to the relative gene expression at the control first week. The scale extends from fluorescence radios of 0.25 to 4 relative to the mean level for all samples. Significance was calculated using least squares means of ANOVA. Gene, GeneCards, GO, etc.) are displayed such that liver necroinflammation and fibrosis, a large amount researchers may easily find the information they of sample is needed. Due to limited sample sources, need. This results in an information-harvesting sysour dataset only goes a small way towards a full untem that supports flexible storage and presentation derstanding of liver fibrogenesis. To strengthen our and provides necessary accurate information to liver dataset, a proprietary liver necroinflammatory and fifibrosis researchers. The system supports both flexibrosis-related gene expression data warehouse has ble storage and presentation. The result is an annotabeen established, consisting of both ours and other tion engine that provides the precise information necpublicly accessible microarray datasets, even though essary for liver fibrosis research. such integration remains difficult. We have downTo organize the histopathological data from the loaded the publicly accessible liver fibrosis microcontrol group and DMN group, a histopathological array dataset (45) and manually keyed-in those genes section has been established in same website. This reported to show differential expression patterns from website contains the 6-week time course dataset and liver fibrosis tissue samples. These collected datasets each experimental week of the histopathological will serve as reference databases for us during further slices taken from 2-7 different rats. In addition, the validation. All of these datasets have been deposited biochemical data for each rat are also included in the and reorganized at a website (http://LiverFibrosis. view panel within the website. nchc.org.tw:8080/LF). We have deposited 24 microarray datasets (12 controls, 12 DMN treated) with four data formats: CEL, TXT, EXP, and DAT for DISCUSSION free download and analysis. In addition, a necroinflammatory and fibrosis-related gene list from the Liver fibrosis represents a continuous disease spectrum characterized by an increase in total liver collapublic accessible microarray datasets and gene annotation is included at this website.
gen and other matrix proteins that disrupt the archi- a significant challenge. This is simply because gene nally identified in lung and kidney endothelial cells, where its expression is regulated by cytokines, espeannotation is scattered and its content is hard to update or improve. Therefore, it was imperative to decially interleukin-6 (IL-6) (6,49). The expression of Esm1 is related to systemic inflammation in adiposign an information-harvesting infrastructure that supports flexible storage and presentation as well as cytes and might play a role in the regulation of the inflammatory processes by a protein kinase C-mediproviding a good content management environment. Using this study, we wish to cause a paradigm shift ated signal pathway (49) . Based on a hepatobiliary disease study, vimentin (Vim), the cytoskeleton gene, by providing a web-based service and by publishing organized information via semantic webs. Softbots, was also found to be overexpressed in bile ductules and interlobular bile ducts. Moreover, vimentin shows or software agents, are implemented to collect scattered gene annotations either by mining data sources a heterogeneous antigenic expression as intermediate filaments in biliary epithelial cells and may be related directly or by querying publicly accessible databases. Because our website is an integrated biological inforto proliferation and reorganization (38) . CD63, a transmembrane protein, is also one of our mation portal with the built-in online editing tools and versatile sharing mechanisms, we welcome other fibrosis gene signatures and is upregulated after DMN treatment. Hepatic stellate cells (HSC), also researchers who might want to contribute their liver fibrosis-related microarray and/or proteomics dataknown as Ito cells, are now well known to be a key cellular element involved in the development of hesets into this public accessible website. Moreover, this website also hyperlinks to the newly established patic fibrosis. Following chronic injury, HSCs activate or differentiate into myofibroblast-like cells, ac-ECHO, the Encyclopedia of Hepatocellular Carcinoma Genes Online (http://ehco.nchc.org.tw), allowquiring contractile, proinflammatory, and fibrogenic properties (30, 35, 36) . Activated HSCs migrate and ing geographically distant researchers to freely access these valuable genomic datasets. Expansion of this accumulate at the sites of tissue repair, secreting large amounts of extracellular matrix proteins during the dataset is part of our continuing effort (by reviewing the literature) aimed at elucidating the transcriptome progression of fibrosis. Activated HSC have been identified as the major collagen (one of extracellular and it will easily allow the inclusion of additional gene expression data contributed by other investigamatrix proteins)-producing cells and an initiator of liver fibrosis when the liver is injured (4). It has been tors worldwide.
Among the necroinflammatory-associated genes, demonstrated that inhibition of CD63 will inhibit collagen secretion and HSC migration (32) . It has been endothelial cell-specific molecule (Esm1) was overexpressed in DMN-treated samples. Esm1 was origisuggested that CD63 might be a novel diagnostic marker for the injured liver. Moreover, in an alcoIn total, 256 genes were identified that were able to discriminate a liver damage situation from the normal holic liver disease (ALD) study (43) , Annexin A1 (Anxa1) was highly expressed after liver injury. A situation; of these, 44 and 62 genes formed the best necroinflammatory and fibrosis discriminators, rerecent study has indicated that alcohol-initiated liver injury occurs via inflammation. ALD progression inspectively. We have used these discriminators to rapidly screen potential Chinese herbs for the treatment volves continuing liver injury, fibrosis, and impaired liver regeneration. It suggested that Anxa1 might play of DMN-induced liver fibrosis. Among many herbs tested, one of them has shown a significant improvea role in the progression of fibrosis.
Chronic inflammation and hepatic cell damage ment in DMN-triggered liver damage as examined by histopathological and clinical biochemical analysis might provide the proliferation stimuli for the promotion of hepatocarcinogenesis (42) . Proteomics analysimilar to those described in this study. More importantly, treatment with this newly identified herb could sis using human primary biliary cirrhosis and normal tissues indicated that SPP1 is also highly expressed reverse more than 80% of these discriminators to the level of the normal control (data not shown). This in primary biliary cirrhosis and is involved in the formation of epithelioid granuloma (18) . Recently, SPP1, result implies that identification of these discriminators not only allows them to serve as molecular claswhich is a secreted matrix protein (33) , has been identified as a lead gene for the HCC signature and sifiers that provide novel biological insights into the development of earlier liver damage but they can also it has been shown to be overexpressed in metastatic HCC. Moreover, SPP1-specific antibodies can block help the development of new therapeutic drugs for liver disease. HCC cell invasion effectively in vitro and also inhibit pulmonary metastasis of HCC cells in nude mice (52). This data comparison supports the view that ACKNOWLEDGMENTS SPP1 not only acts as a potential therapeutic target for metastatic HCC, but also has the potential to be This work was supported in part by grants from the Liver Disease Prevention and Treatment Research an early diagnostic marker for liver injury. Thus, it may be feasible in the future to diagnose patients Foundation, DOH (CCMP 94-RD-047) and National Health Research Institutes to L. J. Su, Taichung Vetwith inflammation and fibrosis using only a serum sample (Fig. 4E) .
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